dr. succaria on targetable immune checkpoints in head and neck cancer
Published 5 years ago • 110 plays • Length 2:10Download video MP4
Download video MP3
Similar videos
-
1:05
dr. succaria on combination immunotherapy in head and neck cancer
-
1:30
dr. burtness on immunotherapy resistance in head and neck cancer
-
0:46
dr. schoenfeld on immunologic effects of chemotherapy and radiation in head and neck cancer
-
8:45
ryan margolis: improve delivery of immune checkpoint inhibitors in head and neck cancer
-
1:05
rationale for evaluating sting agonists in head and neck cancer
-
1:22
dr. burtness on immunotherapy and chemotherapy in head and neck cancer
-
33:42
head and neck cancer and immunotherapy with dr. nabil f. saba
-
1:08
dr. cohen discusses new data on immunotherapies for head and neck cancers
-
34:46
head and neck cancer immunotherapy: progress in treatment, with ezra cohen
-
4:11
next steps in research for immunotherapy for hnscc
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
9:40
emerging agents to treat hnscc
-
1:01:45
immune checkpoint inhibitors: the good, the bad, and the emerging field of cardio-oncology
-
0:39
rationale for targeting fpr2 in female patients with pancreatic cancer
-
1:27
where to go next with pembrolizumab and other anti-pd-1 therapies in head and neck cancer
-
1:12
dr. sampath on immunotherapy and radiation combinations in nsclc
-
46:33
new ways immunotherapy targets breast cancer, with silvia formenti
-
6:14
key points from the adaura trial: osimertinib
-
1:26
skin cancer 101: risk factors